BGLC (BioNexus Gene Lab Corporation) Rasio nilai perusahaan marang pendapatan

Price volatility for polymer raw materials in Southeast Asia is driving the search for new markets, which is reflected in the EV/Revenue multiple, where the value is fixed at -373.80. This growth is based on the expansion of biochemical additives and the implementation of diagnostic tests. BioNexus Gene Lab Corp. (BGLC) maintains fundamental stability through leading geneticists whose developments strengthen the company's position in the region's molecular medicine.
bionexusgenelab.com - rincian analitis lan metrik utama (BGLC)

This indicator compares the total enterprise value, including debt and net of cash, with annual revenue to determine the asset's actual market valuation regardless of capital structure. Analyzing the EV/Sales ratio allows for an assessment of the monetization efficiency of genetic diagnostics and dietary supplement sales at BioNexus Gene Lab Corp. (BGLC), revealing the true investor consensus regarding the value of its operating cash flows.